Correction: Evaluation of a social protection policy on tuberculosis treatment outcomes: A prospective cohort study

Klein, Karen; Bernachea, Maria Paula; Iribarren, Sarah J.; Gibbons, Luz; Chirico, Cristina; Rubinstein, Fernando

doi:10.1371/journal.pmed.1002826

Cited by 8 publications

(20 citation statements)

References 1 publication

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Many studies documented the positive association between receipts of cash transfer and improved treatment outcome 20 22–27. Positive association between DBT receipt and successful treatment outcomes was also found in our study.…”

Section: Discussionsupporting

confidence: 87%

Cash transfer scheme for people with tuberculosis treated by the National TB Programme in Western India: a mixed methods study

Patel¹,

Jeyashree

Chinnakali

et al. 2019

BMJ Open

View full text Add to dashboard Cite

ObjectivesThis study aimed to assess the coverage and explore enablers and challenges in implementation of direct benefit transfer (DBT) cash incentive scheme for patients with tuberculosis (TB).DesignThis is a mixed methods study comprising a quantitative cohort and descriptive qualitative study.SettingThe study was conducted in City TB Centre, Vadodara, Western India.ParticipantsWe used routinely collected data under the National TB Programme (NTP) on patients with TB notified between April and September 2018 and initiated on first-line anti-tuberculosis treatment (ATT) to assess the coverage of DBT. We interviewed NTP staff and patients to understand their perceptions.Primary and secondary outcome measuresThe study outcomes are receipt of DBT (primary), time to receipt of first instalment of DBT and treatment outcome.ResultsAmong 1826 patients, 771 (42.2%) had received at least one instalment. Significantly more patients from the public sector had received DBT (at least one instalment) compared with those from private sector (adjusted relative risk (adjRR)=16.3; 95% CI 11.6 to 23.0). Among public sector patients, 7.3% (49/671) had received first instalment within 2 months of treatment initiation. Median (IQR) time to receipt of first instalment was 5.2 (3.4, 7.4) months. Treatment in private sector, residing outside city limits and being HIV non-reactive were significantly (p<0.001) associated with longer time to receipt. Timely and sufficient fund release, adequate manpower and adequate logistics in TB centre were the enablers. Inability of patients to open bank accounts due to lack of identity/residence proof, their reluctance to share personal information and inadequate support from private providers were the challenges identified in implementation.ConclusionDuring the early phase of DBT implementation, the coverage was low and there were delays in benefit transfer. Facilitating opening of bank accounts for patients by NTP staff and better support from private providers may improve DBT coverage. Repeat assessment of DBT coverage after streamlining of implementation is recommended.

show abstract

Section: Discussionsupporting

confidence: 87%

Cash transfer scheme for people with tuberculosis treated by the National TB Programme in Western India: a mixed methods study

Patel¹,

Jeyashree

Chinnakali

et al. 2019

BMJ Open

View full text Add to dashboard Cite

show abstract

“…(66.6%) (6,(8)(9)11,(13)(14) determined that the incentive of social benefits can enable the effectiveness of providing economic support to patients with pulmonary TB.…”

Section: Resultsmentioning

confidence: 99%

“…Study samples vary between 25 and 25,084 TB patients. A study (11.1%) (8) comprised all patients diagnosed with TB pulmonary disease, sensitive TB and assistance to intervention clinics in the years 2009 and 2010. A survey (11.1%) (10) made it possible to treat 312 families that had TB patients and recruited 90% (282/312), of which 135 households were randomized to the intervention arm and 147 to the control arm.…”

Section: Resultsmentioning

confidence: 99%

“…Due to the relationship between TB and the situation of social vulnerability resulting from poverty (6)(7)(8)(9)(10)(11)(12)(13)(14) , some low-income countries have created social protection programs to intervene in the health social determinants related to TB incidence and mortality. Some studies have shown positive results regarding disease control, treatment adherence and increased cure rates (2)(3) , proving that social protection programs reduce social vulnerability and improve expectations of cure (6)(7)(8)(9)(10)(11)(12)(13)(14) .…”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Impact of social protection programs on adults diagnosed with Tuberculosis: systematic review

et al. 2021

View full text Add to dashboard Cite

Objectives: to analyze the impact of social protection programs on adults diagnosed with Tuberculosis. Methods: systematic review conducted by PRISMA, with registration PROSPERO CRD42019130884. The studies were identified in the VHL, PubMed, Scielo, CINAHL and Scopus databases, using the descriptors “Social Protection” and “Tuberculosis”, in combination with keywords combined with Boolean operators AND and OR. Observational and interventional studies published until October 23, 2019, in Portuguese, English and Spanish, were included. Results: social protection programs improve the treatment of tuberculosis, cure rates, adherence to treatment, the provision of services for the control of TB and reduce poverty. Conclusions: social protection programs have a positive impact on the treatment and control of people diagnosed with Tuberculosis.

show abstract

“…Reports from the NTP for the last 5 years and our cohort study showed that more than 60% of patients with TB were managed in public hospitals and 65% of them received treatment by self-administration. Of these, 85% were of low socioeconomic status, 50% were unemployed, 25% were smokers, and 20% reported alcohol or drug use [ 24 ].…”

Section: Methodsmentioning

confidence: 99%

Mobile Tuberculosis Treatment Support Tools to Increase Treatment Success in Patients with Tuberculosis in Argentina: Protocol for a Randomized Controlled Trial

Iribarren¹,

Milligan²,

Goodwin³

et al. 2021

JMIR Res Protoc

Self Cite

View full text Add to dashboard Cite

Background Tuberculosis (TB) is an urgent global health threat and the world’s deadliest infectious disease despite being largely curable. A critical challenge is to ensure that patients adhere to the full course of treatment to prevent the continued spread of the disease and development of drug-resistant disease. Mobile health interventions hold promise to provide the required adherence support to improve TB treatment outcomes. Objective This study aims to evaluate the effectiveness of the TB treatment support tools (TB-TSTs) intervention on treatment outcomes (success and default) and to assess patient and provider perceptions of the facilitators and barriers to TB-TSTs implementation. Methods The TB-TSTs study is an open-label, randomized controlled trial with 2 parallel groups in which 400 adult patients newly diagnosed with TB will be randomly assigned to receive usual care or usual care plus TB-TSTs. Participants will be recruited on a rolling basis from 4 clinical sites in Argentina. The intervention consists of a smartphone progressive web app, a treatment supporter (eg, TB nurse, physician, or social worker), and a direct adherence test strip engineered for home use. Intervention group participants will report treatment progress and interact with a treatment supporter using the app and metabolite urine test strip. The primary outcome will be treatment success. Secondary outcomes will include treatment default rates, self-reported adherence, technology use, and usability. We will assess patients’ and providers’ perceptions of barriers to implementation and synthesize lessons learned. We hypothesize that the TB-TSTs intervention will be more effective because it allows patients and TB supporters to monitor and address issues in real time and provide tailored support. We will share the results with stakeholders and policy makers. Results Enrollment began in November 2020, with a delayed start due to the COVID-19 pandemic, and complete enrollment is expected by approximately July 2022. Data collection and follow-up are expected to be completed 6 months after the last patient is enrolled. Results from the analyses based on the primary end points are expected to be submitted for publication within a year of data collection completion. Conclusions To our knowledge, this randomized controlled trial will be the first study to evaluate a patient-centered remote treatment support strategy using a mobile tool and a home-based direct drug metabolite test. The results will provide robust scientific evidence on the effectiveness, implementation, and adoption of mobile health tools. The findings have broader implications not only for TB adherence but also more generally for chronic disease management and will improve our understanding of how to support patients facing challenging treatment regimens. Trial Registration ClinicalTrials.gov NCT04221789; https://clinicaltrials.gov/ct2/show/NCT04221789. International Registered Report Identifier (IRRID) DERR1-10.2196/28094

show abstract

Correction: Evaluation of a social protection policy on tuberculosis treatment outcomes: A prospective cohort study

Cited by 8 publications

References 1 publication

Cash transfer scheme for people with tuberculosis treated by the National TB Programme in Western India: a mixed methods study

Cash transfer scheme for people with tuberculosis treated by the National TB Programme in Western India: a mixed methods study

Impact of social protection programs on adults diagnosed with Tuberculosis: systematic review

Mobile Tuberculosis Treatment Support Tools to Increase Treatment Success in Patients with Tuberculosis in Argentina: Protocol for a Randomized Controlled Trial

Contact Info

Product

Resources

About